Certara Inc
Avatud
SektorTervishoid
9.66 3.43
Ülevaade
Aktsiahinna muutus
24h
Min
9.22
Max
9.69
Sissetulek | -380K -9.1M |
|---|---|
Müük | -14M 93M |
P/E Sektori keskmine | 100.714 48.735 |
Aktsiakasum | 0.05 |
Kasumimarginaal | -9.803 |
Töötajad | 1,515 |
EBITDA | -4.2M 12M |
Soovitused | Neutraalne |
|---|---|
12 kuu keskmine prognoos | -3.85% downside |
Järgmine tulemuste avaldamine | 5. nov 2026 |
|---|
Turukapital | 137M 1.4B |
|---|---|
Eelmine avamishind | 6.23 |
Eelmine sulgemishind | 9.66 |
Certara Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Certara Inc Prognoos
Hinnasiht
By TipRanks
-3.85% langus
12 kuu keskmine prognoos
Keskmine 9 USD -3.85%
Kõrge 11 USD
Madal 7 USD
Põhineb 8 Wall Streeti analüütiku instrumendi Certara Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Certara Inc
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
